Waters Parkerson & CO. LLC Sells 237 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Waters Parkerson & CO. LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 30.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 545 shares of the healthcare conglomerate’s stock after selling 237 shares during the period. Waters Parkerson & CO. LLC’s holdings in UnitedHealth Group were worth $275,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Keebeck Wealth Management LLC raised its stake in UnitedHealth Group by 11.6% during the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after buying an additional 1,122 shares during the period. D.A. Davidson & CO. raised its stake in shares of UnitedHealth Group by 24.0% in the second quarter. D.A. Davidson & CO. now owns 42,045 shares of the healthcare conglomerate’s stock worth $20,209,000 after purchasing an additional 8,144 shares during the last quarter. Ascension Capital Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $216,000. Blue Chip Partners LLC raised its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Blue Chip Partners LLC now owns 49,995 shares of the healthcare conglomerate’s stock worth $24,030,000 after purchasing an additional 228 shares during the last quarter. Finally, Physician Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $207,000. 85.69% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the transaction, the director now directly owns 635,528 shares in the company, valued at approximately $349,788,255.92. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Jefferies Financial Group reduced their target price on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a report on Monday, November 20th. Truist Financial reaffirmed a “buy” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Thursday, November 30th. Royal Bank of Canada reissued an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 16th. UBS Group raised UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price objective for the company from $520.00 to $640.00 in a report on Monday, October 16th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Friday, January 19th. One analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $575.79.

View Our Latest Report on UNH

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock opened at $517.68 on Tuesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70. The company has a market capitalization of $478.81 billion, a PE ratio of 21.71, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The business’s fifty day moving average is $524.74 and its 200 day moving average is $517.93.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the previous year, the firm posted $5.34 EPS. The business’s revenue was up 14.1% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.84 EPS for the current fiscal year.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.